Veracyte (VCYT) Research & Development: 2012-2025
Historic Research & Development for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $16.0 million.
- Veracyte's Research & Development fell 9.06% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $69.3 million for FY2024, which is 20.92% up from last year.
- Latest data reveals that Veracyte reported Research & Development of $16.0 million as of Q3 2025, which was down 1.74% from $16.3 million recorded in Q2 2025.
- Over the past 5 years, Veracyte's Research & Development peaked at $19.3 million during Q4 2024, and registered a low of $5.3 million during Q1 2021.
- Its 3-year average for Research & Development is $16.1 million, with a median of $16.3 million in 2025.
- As far as peak fluctuations go, Veracyte's Research & Development surged by 123.55% in 2021, and later decreased by 9.06% in 2025.
- Quarterly analysis of 5 years shows Veracyte's Research & Development stood at $10.3 million in 2021, then increased by 10.10% to $11.3 million in 2022, then spiked by 65.44% to $18.7 million in 2023, then rose by 3.30% to $19.3 million in 2024, then decreased by 9.06% to $16.0 million in 2025.
- Its Research & Development stands at $16.0 million for Q3 2025, versus $16.3 million for Q2 2025 and $17.7 million for Q1 2025.